Multiple Sclerosis

Biotech to the rescue

MIT professor Ram Sasisekharan's three biotech companies—Momenta Pharmaceuticals, Cerulean Pharma, and Visterra—share a similar goal. "It's about the impact we can have on patient care," says Sasisekharan, ...

Apr 28, 2014
popularity 4 / 5 (2) | comments 0

Study suggests targeting B cells may help with MS

A new study suggests that targeting B cells, which are a type of white blood cell in the immune system, may be associated with reduced disease activity for people with multiple sclerosis (MS). The study is released today ...

Apr 24, 2014
popularity not rated yet | comments 0

Latest Spotlight News

New diagnostic approach for autism in Tanzania

Autism is no stranger to the children of Tanzania. What is rare in the East African nation is access to clinical services, including reliable diagnosis and evidence-based treatments. There is no autism diagnostic ...